Download the Protocol

FOXO4

FOXO4 is a naturally occurring protein fragment involved in protecting cells from stress and supporting healthy aging. It helps balance cell renewal and defense systems, playing a role in how cells respond to damage and maintain their function over time. Research focuses on its link to longevity, DNA repair, and mitochondrial health.

Description

• FOXO4 peptide is derived from the Forkhead box O4 transcription factor, a protein involved in regulating cell survival, apoptosis, and aging pathways.
• Research has focused on FOXO4’s role in cellular senescence, mitochondrial health, and genomic stability.
• Unlike FOXO4-DRI (a modified analog), this form represents the unaltered native FOXO4 sequence used for mechanistic studies.

How It Works

• Acts as a transcriptional regulator that modulates stress response, antioxidant defense, and DNA repair genes.
• Maintains cellular homeostasis through modulation of p53 and NF-κB pathways.
• In senescence research, native FOXO4 supports protective signaling rather than senolytic action.

Documented Effects

• Regulates oxidative stress resistance and promotes mitochondrial stability in vitro.
• Associated with DNA repair enhancement and anti-apoptotic gene expression.
• Facilitates healthy cell cycle control and cellular maintenance.

Theoretical Effects

• Potential applications in aging, mitochondrial, and metabolic regulation studies.
• May help balance cellular renewal and stress responses in tissue culture models.
• Not senolytic; acts primarily as a stress response modulator.

Pharmacokinetics

• Half-life: estimated 30–60 minutes after subcutaneous administration (research-based approximation).
• Time to peak concentration: 1–2 hours post-injection.
• Steady-state: not typically achieved; FOXO4 acts transiently on transcription factors.

Duration of Effects

• Cell-protective effects may last several hours to days depending on model and dose.
• Regulatory changes to gene expression can persist beyond measurable clearance.
• Repeat dosing schedules vary widely between research designs.

Reconstitution

• Use only bacteriostatic water to reconstitute the lyophilized powder.
• Example vial: 1 mg of FOXO4
• Choose reconstitution volume based on dosing convenience:
  • 1 mL water → 1 mg/mL → 100 mcg per 10 units
  • 2 mL water → 0.5 mg/mL → 50 mcg per 10 units
• Swirl gently to dissolve; do not shake or heat.
• Refrigerate reconstituted solution (2–8 °C). Use within ~21 days for best stability.

Dosage Overview (Research Use)

Typical Starting Dose

• 50–100 mcg subcutaneous (SC) daily for cell stress or mitochondrial research.
• Conservative entry: 50 mcg per day for 3–5 days before adjustment.

Common Research Range

• 50–200 mcg SC daily depending on experimental design and cell model.
• Not interchangeable with FOXO4-DRI protocols due to different mechanisms.

Maximum Research Range

• Up to 500 mcg SC daily in stress adaptation or antioxidant research models.

Standard Cycle Length

• 2–6 weeks depending on model response and study parameters.
• Cycles are generally followed by equal-length rest periods for balance.

Clinical Notes

• Native FOXO4 acts as a regulator, not a senolytic compound.
• Often compared to FOXO4-DRI for aging and longevity research differentiation.
• Should not be combined with senolytics without clear mechanistic design.
• Stable for about 21 days when refrigerated (2–8°C). Protect from light and heat. Avoid freezing.

Safety Notes (First-Time Use)

• Possible mild fatigue or transient headache during adaptation phase.
• Use sterile technique and confirm compound identity and purity.
• Research use only; not approved for therapeutic human application.